© 2021 RSM US LLP. All rights reserved.
Equity markets largely shrugged off headline risks — the S&P 500 Index posted its seventh straight monthly gain.
July was, on balance, a good month for investors. Many broad market indexes across equity and fixed income posted positive returns.
Global capital markets posted modest gains during May with value stocks outpacing their growth counterparts and international markets.
U.S. business activity registered a substantial increase at the end of the first quarter of 2021. Find out why.
March was another strong month for risk assets, especially in the U.S. as vaccine manufacturing and distribution ramped up.
Equities rallied, notably small cap and value stocks, amid more vaccine progress and the anticipation of more stimulus.
While we are constructive on near-term markets, we will focus on the rebound in business activity following progress with the vaccine.
November displayed the forward-looking nature of markets as global equities reacted positively that a vaccine may be distributed in 2021.
Rising COVID-19 cases and a failure from policy makers to pass further fiscal stimulus weighed on equity markets.
U.S. dollar strengthened in September as the existing monetary stimulus wane and expectations for fiscal stimulus before the election fade.